検索結果 - John Bridgewater
-
1
Reply to J. Edeline et al 著者: John Bridgewater, Peter Fletcher, John Primrose
出版事項 2022Carta -
2
-
3
Targeting FGFR inhibition in cholangiocarcinoma 著者: Lipika Goyal, Sarinya Kongpetch, Valerie Crolley, John Bridgewater
出版事項 2021Revisão -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial 著者: Thomas Gruenberger, John Bridgewater, Ian Chau, Pilar Alfonso, Michel Rivoire, Satvinder Mudan, S. Lasserre, Matthias Hermann, Daniel Waterkamp, René Adam
出版事項 2014Artigo -
12
Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies 著者: Tal Grenader, Stephen Nash, Yevgeni Plotkin, Junji Furuse, Nobumasa Mizuno, Takuji Okusaka, Harpreet Wasan, Juan W. Valle, John Bridgewater
出版事項 2015Artigo -
13
-
14
-
15
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study 著者: John Bridgewater, Andre Lopes, Sandra Beare, Marian Duggan, Dymphna Lee, Maravic Ricamara, Delyth McEntee, Ajithkumar Sukumaran, Harpreet Wasan, Juan W. Valle
出版事項 2016Artigo -
16
-
17
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1–4 Inhibitor: Pooled Safety Analysis of 469 Patients 著者: Funda Meric‐Bernstam, Antoine Hollebecque, Junji Furuse, Do‐Youn Oh, John Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
出版事項 2024Artigo -
18
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial 著者: S. Pugh, Raphaële Thiébaut, John Bridgewater, Marie-Lise Grisoni, Karwan Moutasim, Francis Rousseau, Gareth J. Thomas, Gareth Griffiths, François Liebaert, John Primrose, Pierre Laurent‐Puig
出版事項 2017Artigo -
19
Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials 著者: Ángela Lamarca, Paul J. Ross, Harpreet Wasan, Richard Hubner, Mairéad G. McNamara, Andre Lopes, Prakash Manoharan, Daniel G. Palmer, John Bridgewater, Juan W. Valle
出版事項 2019Artigo -
20
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 著者: Arndt Vogel, John Bridgewater, Julien Edeline, Robin Kate Kelley, Heinz‐Josef Klümpen, David Malka, John Primrose, Lorenza Rimassa, Albrecht Stenzinger, Juan W. Valle, Michel Ducreux
出版事項 2022Artigo
関連主題
Medicine
Internal medicine
Oncology
Cancer
Colorectal cancer
Chemotherapy
Biology
Gastroenterology
Gemcitabine
Surgery
Oxaliplatin
Biliary tract cancer
Cetuximab
Randomized controlled trial
Confidence interval
Biliary tract
Biochemistry
Clinical endpoint
Pathology
Cancer research
Capecitabine
Clinical trial
Gene
Hazard ratio
KRAS
Phases of clinical research
Cisplatin
Environmental health
FOLFOX
Fluorouracil